Home
Conditions
Philadelphia Chromosome

Clinical trial condition

Philadelphia Chromosome

Explore clinical trials studying Philadelphia Chromosome. Study availability and eligibility vary by location and protocol.

31 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Philadelphia Chromosome trial results

Completed

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

NCT01061177

Conditions: CML in Chronic Phase, Chromosome Aberrations, Hematologic Diseases, +8 more
Locations: Novartis Investigative Site Wels, Austria

Novartis Investigative Site Graz, Austria

Novartis Investigative Site Innsbruck, Austria

Novartis Investigative Site Linz, Austria

View all 320 locations

View Trial Details

Completed

Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

NCT00428909

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Novartis Investigative Site Seoul, South Korea

View Trial Details

Completed

Effect of Food on Bioavailability of Modified Release Formulations of Imatinib

NCT00420043

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Not specified

View Trial Details

Completed

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

NCT00422825

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

NCT01254188

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Novartis Investigative Site Algiers, Bouzareah, Algeria

Novartis Investigative Site Oran, Algeria

Novartis Investigative Site Buenos Aires, Argentina

Novartis Investigative Site Caba, Buenos Aires, Argentina

View all 100 locations

View Trial Details

Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Local Institution Jakarta, Indonesia

Local Institution Batangas, Philippines

Local Institution Manila, Philippines

Local Institution Busan, South Korea

View all 22 locations

View Trial Details

Completed

Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive

NCT00763763

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +25 more
Locations: Service Clinique des Maladies du Sang Paris, France

View Trial Details

Completed

Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

NCT00130195

Conditions: Acute Lymphoblastic Leukemia, Chromosome Aberrations, Hematologic Diseases, +14 more
Locations: Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan

View Trial Details

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

NCT00511303

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

NCT04971226

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Rocky Mountain Cancer Centers Denver, Colorado, United States

Florida Cancer Specialists Fort Myers, Florida, United States

Florida Cancer Specialists Pan Tallahassee, Florida, United States

University of Kentucky Lexington, Kentucky, United States

View all 110 locations

View Trial Details

Philadelphia Chromosome

Philadelphia Chromosome trial results

Related conditions